Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
473.02
426.56
422.71
331.02
520.50
456.54
418.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
473.02
426.56
422.71
331.02
520.50
456.54
418.70
Raw Material Cost
209.46
130.75
164.93
151.52
228.92
137.17
136.26
Purchase of Finished goods
6.30
0.15
2.29
7.26
25.00
7.99
8.43
(Increase) / Decrease In Stocks
-11.67
16.56
13.15
36.40
-60.82
0.59
-21.29
Employee Cost
133.96
123.92
111.14
95.93
135.81
111.79
104.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
-6.16
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
142.20
154.21
145.22
132.20
175.26
123.30
142.95
Total Expenditure (Excl Depreciation)
480.25
425.59
436.73
423.31
504.17
380.84
364.47
Operating Profit (PBDIT) excl Other Income
-7.23
0.97
-14.02
-92.29
16.33
75.70
54.23
Other Income
14.35
12.07
14.99
36.60
6.92
5.08
11.71
Operating Profit (PBDIT)
7.12
13.04
0.97
-55.69
23.25
80.78
65.94
Interest
4.85
2.84
2.76
3.39
150.18
138.43
129.52
Exceptional Items
16.79
8.28
33.29
83.28
0.00
0.00
-15.40
Gross Profit (PBDT)
19.06
18.48
31.50
24.20
-126.93
-57.65
-78.98
Depreciation
25.18
26.39
27.90
29.61
32.51
34.02
33.17
Profit Before Tax
-6.12
-7.91
3.60
-5.41
-159.44
-91.67
-112.15
Tax
0.04
-1.18
3.11
15.66
0.04
0.47
7.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-6.16
-6.73
0.49
-21.07
-159.48
-92.14
-119.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
-1.45
-5.12
Net Profit
-6.16
-6.73
0.49
-21.07
-159.48
-93.59
-124.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.08
0.17
Minority Interest
0.09
-0.08
0.08
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-5.89
-6.65
0.41
-21.07
-159.48
-93.51
-124.59
Equity Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
0.65
0.74
-0.37
3.16
-8.03
-6.54
-3.48
Operating Profit Margin (Excl OI)
-1.53%
0.23%
-3.32%
-27.88%
3.14%
16.58%
12.95%
Gross Profit Margin
4.03%
4.33%
7.45%
7.31%
-24.39%
-12.63%
-18.86%
PAT Margin
-1.3%
-1.58%
0.12%
-6.37%
-30.64%
-20.18%
-28.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 10.89% vs 0.91% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 11.43% vs -1,721.95% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is -845.36% vs 106.92% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 70.77% vs 2.90% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Panacea Biotec With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
473.02
1,626.73
-1,153.71
-70.92%
Other Operating Income
0.00
0.00
0.00
Total Operating income
473.02
1,626.73
-1,153.71
-70.92%
Raw Material Cost
209.46
584.80
-375.34
-64.18%
Purchase of Finished goods
6.30
139.70
-133.40
-95.49%
(Increase) / Decrease In Stocks
-11.67
28.03
-39.70
-141.63%
Employee Cost
133.96
306.82
-172.86
-56.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
142.20
433.93
-291.73
-67.23%
Total Expenditure (Excl Depreciation)
480.25
1,493.28
-1,013.03
-67.84%
Operating Profit (PBDIT) excl Other Income
-7.23
133.45
-140.68
-105.42%
Other Income
14.35
39.59
-25.24
-63.75%
Operating Profit (PBDIT)
7.12
173.04
-165.92
-95.89%
Interest
4.85
22.20
-17.35
-78.15%
Exceptional Items
16.79
217.26
-200.47
-92.27%
Gross Profit (PBDT)
19.06
368.10
-349.04
-94.82%
Depreciation
25.18
94.51
-69.33
-73.36%
Profit Before Tax
-6.12
273.59
-279.71
-102.24%
Tax
0.04
31.66
-31.62
-99.87%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-6.16
241.93
-248.09
-102.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-6.16
241.93
-248.09
-102.55%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.09
0.00
0.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-5.89
241.93
-247.82
-102.43%
Equity Capital
6.13
14.08
-7.95
-56.46%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
4.03%
22.63%
0.00
-18.60%
PAT Margin
-1.30%
14.87%
0.00
-16.17%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 473.02 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 10.89% vs 0.91% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit -5.89 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 11.43% vs -1,721.95% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -7.23 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -845.36% vs 106.92% in Dec 2024
Nine Monthly - Interest
Interest 4.85 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 70.77% vs 2.90% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1.53%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
